國立高雄大學圖資館 |

Language: English

Back

Nuclear medicine in oncologymolecula...

Huang, Gang.

Nuclear medicine in oncologymolecular imaging and target therapy /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Nuclear medicine in oncologyedited by Gang Huang.
Reminder of title:	molecular imaging and target therapy /
other author:	Huang, Gang.
Published:	Singapore :Springer Singapore :2019.
Description:	xi, 346 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Nuclear medicine.
Online resource:	https://doi.org/10.1007/978-981-13-7458-6
ISBN:	9789811374586$q(electronic bk.)

Nuclear medicine in oncologymolecular imaging and target therapy /
Nuclear medicine in oncologymolecular imaging and target therapy /[electronic resource] :edited by Gang Huang. - Singapore :Springer Singapore :2019. - xi, 346 p. :ill., digital ;24 cm.

This book introduces molecular imaging and Target Therapy in various cancers. The first part is the subjects and primary focused on the basics of nuclear physics, radiation dosimetry, nuclear medicine equipment and small animal imaging equipment. The second part is about the radiopharmaceutical and commonly used clinical radiopharmaceuticals, including positron emission imaging agent, single photon emission imaging agent, and radionuclide therapy agents as well as their radioactive preparation, quality control, and a brief clinical application were included. Also, this part introduces a number of new imaging agents which were potential value of clinical applications. In the third part, the clinical application of the conventional imaging agent 18F-FDG in different tumors and neurodegenerative diseases and 18F-Dopa imaging in the nervous system are discussed. Besides the clinical applications of 99mTc labeled radiopharmaceuticals in parathyroid disease, coronary heart disease, myocardial infarction, sentinel lymph node, metastatic bone tumors, liver and gallbladder disease in children are introduced. Finally, the applications of radionuclide 131I on treatments of Graves' disease and differentiated thyroid cancer and metastases are investigated respectively. This book is a useful reference for professionals engaged in nuclear medicine and clinical research, including clinical nuclear medicine physicians, nuclear medicine engineers and nuclear medicine pharmacists.

ISBN: 9789811374586$q(electronic bk.)

Standard No.: 10.1007/978-981-13-7458-6doiSubjects--Topical Terms:

275897
Nuclear medicine.

LC Class. No.: R895 / .N83 2019

Dewey Class. No.: 616.07575

Nuclear medicine in oncologymolecular imaging and target therapy /
LDR:02442nmm a2200313 a 4500 001 563072
003 DE-He213
005 20190620141320.0
006 m d
007 cr nn 008maaau
008 200227s2019 si s 0 eng d
020 $a 9789811374586$q(electronic bk.)
020 $a 9789811374579$q(paper)
024 7 $a 10.1007/978-981-13-7458-6 $2 doi
035 $a 978-981-13-7458-6
040 $a GP $c GP
041 0 $a eng
050 4 $a R895 $b .N83 2019
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.07575 $2 23
090 $a R895 $b .N964 2019
245 0 0 $a Nuclear medicine in oncology $h [electronic resource] : $b molecular imaging and target therapy / $c edited by Gang Huang.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a xi, 346 p. : $b ill., digital ; $c 24 cm.
520 $a This book introduces molecular imaging and Target Therapy in various cancers. The first part is the subjects and primary focused on the basics of nuclear physics, radiation dosimetry, nuclear medicine equipment and small animal imaging equipment. The second part is about the radiopharmaceutical and commonly used clinical radiopharmaceuticals, including positron emission imaging agent, single photon emission imaging agent, and radionuclide therapy agents as well as their radioactive preparation, quality control, and a brief clinical application were included. Also, this part introduces a number of new imaging agents which were potential value of clinical applications. In the third part, the clinical application of the conventional imaging agent 18F-FDG in different tumors and neurodegenerative diseases and 18F-Dopa imaging in the nervous system are discussed. Besides the clinical applications of 99mTc labeled radiopharmaceuticals in parathyroid disease, coronary heart disease, myocardial infarction, sentinel lymph node, metastatic bone tumors, liver and gallbladder disease in children are introduced. Finally, the applications of radionuclide 131I on treatments of Graves' disease and differentiated thyroid cancer and metastases are investigated respectively. This book is a useful reference for professionals engaged in nuclear medicine and clinical research, including clinical nuclear medicine physicians, nuclear medicine engineers and nuclear medicine pharmacists.
650 0 $a Nuclear medicine. $3 275897
650 0 $a Cancer $x Radiotherapy. $3 274201
650 1 4 $a Oncology. $3 195181
650 2 4 $a Nuclear Medicine. $3 275838
650 2 4 $a Interventional Radiology. $3 275855
700 1 $a Huang, Gang. $3 776171
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-13-7458-6
950 $a Medicine (Springer-11650)